Philip Lacap

Rapid, low-cost, and portable molecular detection of HIV-1 subtype B and HCV 1a directly from blood

Accessible molecular diagnostics for human immunodeficiency virus-1 (HIV-1) and hepatitis C virus (HCV) remain constrained by the cost and infrastructure requirements of existing molecular point-of-care platforms. In this study, we describe a portable, proof-of-concept molecular...